About
Build, maintain and scale data pipelines and models that power analytics, reporting, and self-service exploration.
Collaborate with BI engineers, product managers, and engineering teams to translate business needs into reliable data solutions.
Support data governance, including data quality monitoring and audits.
Contribute to the evolution of the BI data platform by applying best practices in data modeling, orchestration, and governance.
Investigate and resolve complex data issues in par...
Updates & Highlights
MarketBeat · 1 day ago
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital
Investing.com · 1 day ago
Rothschild Redburn initiates Tempus AI stock coverage at Neutral
finance.yahoo.com · 1 day ago
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Tempus AI?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentTempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital
MarketBeat · 1 day ago
Rothschild Redburn initiates Tempus AI stock coverage at Neutral
Rothschild Redburn initiates Tempus AI stock coverage at Neutral
Investing.com · 1 day ago
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
finance.yahoo.com · 1 day ago
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
beincrypto.com · 1 day ago
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI
TradingView · 2 days ago
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS)
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS)
Seeking Alpha · 2 days ago
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc.
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc.
MarketBeat · 2 days ago
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM
MarketBeat · 3 days ago
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation
finance.biggo.com · 4 days ago
Does Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption?
Does Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption?
simplywall.st · 5 days ago
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum
Quiver Quantitative · 5 days ago
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan
stocktitan.net · 6 days ago
Tempus AI (TEM) director’s stock sale follows preset plan
Tempus AI (TEM) director’s stock sale follows preset plan
stocktitan.net · 6 days ago
Tempus AI (TEM) director sells 676 shares under preset plan
Tempus AI (TEM) director sells 676 shares under preset plan
stocktitan.net · 6 days ago
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat?
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat?
finance.yahoo.com · 7 days ago
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says
Benzinga · 7 days ago
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000
The Motley Fool · 7 days ago
Tempus AI shares rise 2.7% following analyst actions
Tempus AI shares rise 2.7% following analyst actions
finance.yahoo.com · 8 days ago
Tempus AI receives FDA clearance for pulmonary hypertension tool
Tempus AI receives FDA clearance for pulmonary hypertension tool
MobiHealthNews · 15 days ago
Why Tempus AI Skyrocketed This Week
Why Tempus AI Skyrocketed This Week
finance.yahoo.com · 17 days ago